Zacks Investment Research on MSN
Why Vertex Pharmaceuticals (VRTX) dipped more than broader market today
Vertex Pharmaceuticals (VRTX) ended the recent trading session at $470.10, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Investor's Business Daily on MSN
Dow Jones leader Amgen leads these biotech stocks heading into Q4 earnings season
Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results